Definition of "late-onset" fetal growth restriction Late fetal growth restriction (FGR) is usually defined as that diagnosed >32 weeks of pregnancy. One study 1 showed that a cut-off of 32 weeks at diagnosis or 34 weeks at delivery maximized the clinical differences between early-and late-onset FGR, in terms of perinatal mortality (7.1% vs 0%; P < .001), adverse perinatal outcome (13.4% and 4.6%; P <.001), and association with preeclampsia (35.1% vs 12.1%; P < .001). More recently, a survey was conducted on 45 experts aiming at reaching consensus on the definition of late vs early FGR. 2 There was good agreement (89%) in defining late FGR as that diagnosed >32 weeks.
While in early-onset FGR the typical pattern of deterioration progresses from escalating abnormalities in Doppler parameters to abnormal biophysical parameters, 3, 4 in late-onset FGR there is a common pattern of normal or minimally elevated umbilical Doppler indices with mildly abnormal cerebral Doppler, but without obvious cardiovascular changes beyond these findings. 5, 6 Contrary to early-onset FGR, in late-onset FGR the association with preeclampsia is weak. 7 The Table shows the main differential features between both clinical subtypes.
Another major source of terminological confusion is the distinction between pathologically and constitutionally small fetuses. By convention, both clinical forms have been termed as "fetal growth restriction" and constitutional "smallness for gestational age" (SGA), respectively. Whereas FGR represents a pathological condition (mainly associated with placental insufficiency 8 ) associated with adverse perinatal outcome, constitutional smallness is associated with near-normal perinatal outcomes as it represents the lowest end of the size spectrum of normal fetuses.
Short-and long-term consequences of late FGR Neonatal and infant consequences
Approximately one third of the medically indicated late preterm births are complicated with FGR. 9 Late FGR is associated with cesarean delivery for fetal distress, neonatal acidosis, and admission to the neonatal unit. 10 The association with harder hypoxic events emerges when large cohorts are analyzed. MendezFigueroa et al, 11 in a cohort of 5416 term, uncomplicated pregnancies with SGA (birthweight [BW] <10th centile) found a higher incidence of neonatal death (1.1 vs 0.4/1000 births; adjusted odds ratio [OR], 2.56; 95% confidence interval [CI], 1.83e3.57). In another recent study, Chauhan et al 12 evaluated in a cohort of 115,502 uncomplicated pregnancies of nonanomalous singletons born at term the association between SGA (<10th centile of BW: n ¼ 4983) and hypoxic composite neonatal morbidity including 5-minute Apgar score <5 (prevalence among SGA 0.4%), hypoxic By consensus, late fetal growth restriction is that diagnosed >32 weeks. This condition is mildly associated with a higher risk of perinatal hypoxic events and suboptimal neurodevelopment. Histologically, it is characterized by the presence of uteroplacental vascular lesions (especially infarcts), although the incidence of such lesions is lower than in preterm fetal growth restriction. Screening procedures for fetal growth restriction need to identify small babies and then differentiate between those who are healthy and those who are pathologically small. First-or second-trimester screening strategies provide detection rates for late smallness for gestational age <50% for 10% of false positives. Compared to clinically indicated ultrasonography in the third trimester, universal screening triples the detection rate of late smallness for gestational age. As opposed to early third-trimester ultrasound, scanning late in pregnancy (around 37 weeks) increases the detection rate for birthweight <3rd centile. Contrary to early fetal growth restriction, umbilical artery Doppler velocimetry alone does not provide good differentiation between late smallness for gestational age and fetal growth restriction. A combination of biometric parameters (with severe smallness usually defined as estimated fetal weight or abdominal circumference <3rd centile) with Doppler criteria of placental insufficiency (either in the maternal [uterine Doppler] or fetal [cerebroplacental ratio] compartments) offers a classification tool that correlates with the risk for adverse perinatal outcome. There is no evidence that induction of late fetal growth restriction at term improves perinatal outcomes nor is it a cost-effective strategy, and it may increase neonatal admission when performed <38 weeks. 
Long-term consequences
At long term, the effects of SGA are more difficult to disentangle from other environmental factors. However, a recent cohort 17 (n ¼ 1,100,980) study that adjusted for maternal and paternal educational level found that term SGA was significantly associated with an increased risk of poor school performance at the time of graduation from compulsory school (grades <10th percentile), with adjusted OR and 95% CI ranging from 1.85 (1.65e2.07) for severe SGA (<3 SD of BW) to 1.5 (1.43e1.58) for moderate SGA (BW e2 to e3 SD). In a subanalysis, all BW groups were associated with an increased risk of poor school performance among boys with short stature (10.1% of those individuals born with a BW <2 SD) compared to those with nonshort stature. Finally, it has been suggested that fetal programing also operates in term SGA babies, 18 predisposing them to a higher incidence of metabolic syndrome. Another recent large cohort study 19 on 49,927 female nurses found that term SGA (<10th centile of BW) was associated with an increased risk of adult-onset (diagnosed >30 years) diabetes mellitus (OR, 2.42; 95% CI, 1.44e4.07, adjusted for body mass index and parental history of diabetes).
Placental histopathological findings in late FGR
Placentas from FGR fetuses delivered at term have significantly increased frequencies of uteroplacental vascular lesions (especially infarcts) compared to normal controls, although the incidence of such lesions is much lower than in preterm FGR. [20] [21] [22] Furthermore, it has been reported that compared to normal term pregnancies, placentas from FGR at term may have an increased incidence of other villous lesions including fibrosis, hypovascularity, and avascularity, suggestive of fetal thrombotic events. 23 Hence, differences in placental histopathological findings between late and early FGR are more quantitative (in severity and extension) rather than qualitative. 24 A series of 142 placentas from singleton SGA pregnancies born >34 weeks with normal umbilical artery (UA) Doppler velocimetry found that 54.2% had placental weights <3rd percentile (compared to 9.9% of 142 placentas from normally grown babies; P < .001). Only 21.8% (31/142) of SGA placentas were free of histological abnormalities, while it was 74.6% (106/ 142) in the normally grown group (P < .001). In the abnormal SGA placentas (111/142) there were a total of 161 lesions (classified according standardized criteria 25 Screening for late SGA Since failure to achieve growth potential is a concept difficult to gauge, fetal size is used as a proxy, with all its limitations. Therefore, traditionally, a SGA fetus has been regarded as equivalent of FGR. However, a distinction between FGR (with an increased risk of perinatal complications) and low-risk SGA would be desirable.
The importance of diagnosing late small fetuses An audit on 1543 cases of perinatal death (>28 weeks of gestational) 29 revealed that a failure to detect FGR accounted for 10% of the avoidable cases (those in which panel agreement was met that suboptimal care contributed to the fatal outcome), although no stratification was provided for late vs early FGR. A large study 30 reported a significantly increased risk of fetal death in SGA delivered >37 weeks compared to those delivered in the 37th week (47/10,000; 95% CI, 34.6e62.5 vs 21/10,000; 95% CI, 13.0e32.1; RR, 2.2; 95% CI, 1.3e3.7). Another study including 92,218 singletons found fetal death rates of 9.7 vs 18.9/1000 with antenatally detected vs nondetected FGR. 31 Gestational age in both groups differed by only 10 days (270 vs 280 days), which underscores the relevance of detection and timely delivery.
Early screening
First-or second-trimester screening with uterine Doppler velocimetry, biochemical markers (angiogenic factors), and maternal characteristics may detect early-onset growth restriction in up to 90%. 7 However, late-onset growth restriction is still largely unpredicted. Most studies addressing first-trimester screening for late FGR, used SGA as a proxy, reporting detection rates (DR) for a 10% of false positives ranging from 25% (with only uterine artery [UtA] Doppler velocimetry) 32 to 51% (combining maternal characteristics, blood pressure, uterine Doppler velocimetry, pregnancyassociated plasma protein-A, and placental growth factor). 33 35 Similarly, in a large series 36 of 8024 pregnancies (nulliparous women) uterine Doppler velocimetry (elevated pulsatility index) was evaluated at 16-22þ6 weeks showing limited performance in predicting BW <5th centile: (DR of 45.5% for 25% of false positives). Incorporating maternal age, early pregnancy body mass index, race/ethnicity, smoking status prior to pregnancy, chronic hypertension, and pregestational diabetes in the prediction model resulted in only modest improvements. Finally, combining maternal characteristic, firsttrimester blood pressure, and secondtrimester biometrics and uterine Doppler velocimetry, 43.3% of DR for 10% of false positives has been reported. 37 Therefore, early screening for late FGR is of limited value.
Fundal height
In low-risk pregnancies, serial measurements of symphysis-fundal height (SFH) is recommended as a simple and inexpensive screening tool. 38, 39 Only 1 randomized controlled trial 40 addressed the incremental yield of fundal height measurement over abdominal palpation, showing a nonsignificant improvement of 32% (95% CI, e8% to 90%) in detecting neonatal SGA. Furthermore, the meta-analysis of 34 studies (most of them hospital-based, which may bias the results toward overoptimistic performance) showed a DR of SFH for SGA of w60% for a false-positive rate of w15%, concluding that the method is unsuitable for primary screening. 41 Although SFH determination is of limited value in routine obstetrical care, it continues to be the only physical examination screening test available. Furthermore, the studies do not report separate information on early and late clinical subtypes, nor differentiate between SGA and FGR.
Ultrasound fetal biometry
A meta-analysis of randomized trials failed to demonstrate benefit from routine third-trimester scan. 42 It may be argued that the older pooled data hold limited contemporary validity. Technology and expertise in the 1970s and 1980s do not translate legitimately into current practice. The most recent study 43 was dated 2003 and it claimed a 30% reduction in SGA. Some of studies also relied on outdated surrogates of fetal growth or formulas to EFW. 44, 45 Furthermore, many of the studies involved no change in management if a diagnosis of FGR was made, which does not reflect current practice.
A total of 13 series 37,46-57 on routine ultrasound screening that performed the scan at a mean gestational age >32 weeks have been published since 2012, including a total of 22,927 pregnancies with 1776 SGA babies. SGA was variably defined as BW <10th centile or <5th centile. The summary receiver operating characteristic curve showed an area under the curve of 88.2% (95% CI, 85.4e91%) (Figure 1 and Appendix). For a false-positive rate of 10%, the resulting DR was 70% (95% CI, 62e78%). Only in 1 study 37 The main questions for the use of ultrasound in the detection of small fetuses are: (1) whether it must be systematic or only focused on a selected population by high-risk factors; (2) which is the optimal parameter, ie, EFW, abdominal circumference (AC), or both; and (3) what the optimal gestational age would be.
Systematic vs selective ultrasound
Serial scanning is recommended in highrisk pregnancies, 38 ,39 based on expert opinion. Although up to 25% of the maternity population fall into the category that would require serial scanning based on risk factors, 58 the DR for SGA of such a strategy is <50%. 59 A large prospective study 57 has been published involving 3977 nulliparous women, in which serial scanning was performed at 28, 32, and 36 weeks and the results were concealed to participants and treating clinicians. This series reported that universal screening triples the DR of SGA as compared with screening based on clinical risk factors (from 69 [20%] of 352, to 199 [57%] of 352). Several factors could account for the variability of the reported performances of thirdtrimester ultrasound screening, such as baseline risk of the population, the gestational age at scan (being the performance better late in the third trimester 47, 56 ), and the parameter used for growth assessment AC alone vs EFW.
EFW vs AC
While the American Congress of Obstetricians and Gynecologists supports only the use of EFW <10th percentile, the Royal College of Obstetricians and Gynecologists supports the use of AC <10th percentile as an additional criterion. 38, 39 Indeed, a recent systematic review and meta-analysis on this issue 60 found that AC is comparable to EFW in predicting SGA. The largest prospective study 46 (including 5515 singleton pregnancies routinely scanned at 35-37 weeks) favors EFW over individual biometric measures: for a 5% of false-positive rate the detection for severe SGA (<3rd centile) requiring delivery within 2 weeks of assessment (that could be considered a proxy for FGR) was 83.3% (95% CI, 67.2e93.6) for a combination of fetal biometrics (AC, head circumference, and femur length) plus maternal characteristics and 91.7% (95% CI, 77.5e98.2) for EFW plus maternal characteristics. Individual performance of each biometric measure was not provided.
Optimal gestational age for screening
A meta-analysis of randomized trials failed to demonstrate benefit from routine third-trimester scan. 42 However, of the included studies only 3 of them 43, 45, 61 (contributing only 12% of subjects overall) performed the scan >34 weeks. Therefore, the relevance of this meta-analysis to current clinical practice could be questionable. A recent randomized study 56 compared in low-risk pregnancies routine screening at 32 (n ¼ 1272) vs 36 (n ¼ 1314) weeks. For FGR at birth (<10th customized centile at birth), the false-positive rates for both strategies were similar (6.4% vs 8.2%), but the DR were superior at 36 vs 32 weeks' gestation (38.8% vs 22.5%; P ¼ .006). Likewise, for severe smallness (<3rd customized centile at birth), for a similar rate of false positives (8.5% vs 8.7%), DR was superior at 36 vs 32 weeks' gestation (61.4% vs 32.5%; P ¼ .008). Two prospective studies 46, 62 carried out on the same population showed that while universal screening (maternal characteristics plus EFW) at 30-34 weeks had a DR of 65% (10% of false positives) of 1727 babies born with a BW <5th centile, at 34-37 weeks the DR was 80% (10% of false positives) of 278. Summary receiver operating characteristic curve (SROC)* of studies on routine ultrasound for smallness for gestational age screening performed at mean gestational age >32 weeks. *Random (DerSimonian method) effects model: Walter SD. Properties of summary receiver operating characteristic (SROC) curve for diagnostic test data. The methodology used to construct the data can be found in Stat Med 2002;21:1237-56.
AUC, area under curve; SGA, small for gestational age. ajog.org Expert Reviews SGA vs FGR Once the diagnosis of a small fetus has been established, the next step is the differential diagnosis between FGR and constitutional smallness. Indeed, SGA represent a heterogeneous population that comprises fetuses that fail to achieve their growth potential mainly due to placental insufficiency along with a fraction of the small babies who are only are constitutionally small (ie, they have a low growth potential). Further complexity is added by the fact that histological 63 66 In addition, the follow-up of a cohort of 292 late SGA babies found that severe smallness (<3rd centile) was the most predictive factor for neurological problems at 2 years of life as defined by an abnormal score in the Ages and Stages Questionnaire (ASQ) (OR, 3.6; 95% CI, 1.5e8.8). 67 Thus, severe smallness by itself could be seen as a stand-alone criterion for FGR. Fetuses with severe smallness are overrepresented among the prenatally suspected late SGA fetuses (w30%) because they are more likely to be detected antenatally.
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Velocity of biometric parameters Some reports [69] [70] [71] [72] in high-risk populations have shown that defective longitudinal fetal growth is associated with adverse perinatal outcome. In these series, "high-risk" was variably defined by maternal characteristics (age >35 years, smoking), obstetric history (previous FGR or hypertensive diseases), or EFW/ AC <10th centile.
Several recent studies used serial ultrasound evaluations of fetal growth as a strategy to improve diagnosis of FGR. The first, conducted by Sovio et al 57 in a large cohort of 3977 unselected nulliparous women, found a significant association of second-to third-trimester growth velocity to the occurrence of adverse outcome. Upon stratification, the association remained only significant for those cases (n ¼ 560) with EFW <10th centile (RR, 1.96; 95% CI, 1.21e3.19). The effect of SGA on adverse outcome was significantly modified by the presence of low growth velocity, to a greater extent than by the presence of abnormal umbilical or uterine Doppler velocimetry.
On the other hand, Karlsen et al, 73 in a prospective cohort of 211 pregnancies at risk of SGA (24.6% of them with an EFW <5th centile), aimed at evaluating whether the use of conditional growth centiles could improve the prediction of adverse outcome. This method uses a previous measurement to condition individualized ranges for the subsequent measurement. 74 Using a 5th centile threshold, for adverse outcome, the specificity of 78% (95% CI, 70e84%) using size centile as a predictor was improved to 94% (95% CI, 89e97%) when conditional growth centile was added to the model, whereas the sensitivity was not significantly changed (60% [95% CI, 49e69%] vs 39% [95% CI, 30e50%]). The combination of growth velocity with Doppler parameters for predicting adverse outcome was not explored in this series.
In a series 75 Also recently, we reported on a cohort of 472 SGA-suspected fetuses that longitudinal growth assessment from diagnosis to delivery does not add to other Doppler parameters in predicting adverse perinatal outcome. 76 Indeed, recent evidence on retrospective series 77, 78 shows that there is a correlation between growth velocity and the umbilical/cerebral Doppler. However, when the association to adverse outcomes has been addressed, only the Doppler parameter remained independently associated. 77 There is not a clear definition of slow growth. A recent consensus on the definition of late FGR 2 proposed defining slow growth when AC/EFW crosses 50 centiles between 2 measurements (for instance, from the 75th centile in a first measurement to the 25th centile in second measurement). However, it could be argued that this definition is arbitrary and lacking interval time frame: the same amount of decline over a short time interval would be seen as more concerning. Despite fetal growth, velocity assessment is an intuitive notion that is in keeping with how postnatal growth assessment is performed; the evidence supporting its use is unclear.
Doppler parameters
There is a sizable body of evidence showing that the UA velocimetry does not reliably reflect placental insufficiency and does not reliably predict adverse outcome in late-onset FGR. 5, 69, 79 It is intriguing that while most cases of 83, 84 and neurobehavior, both at birth 85 and at 2 years of age. 86 Furthermore, the CPR, which combines the pulsatility index of the MCA and UA, has been demonstrated to be more sensitive to hypoxia (defined as a reduced partial pressure of oxygen [pO2] in the arterial system) than its individual components 87 and it correlates better with adverse outcome. [88] [89] [90] In addition to these brain Doppler parameters, abnormal UtA Doppler has been associated with an increased risk of intrapartum fetal distress, emergency cesarean delivery, and admission to intensive care unit. 84 Interestingly, a study comparing routine induction at 37 weeks for all SGA detected cases with selective induction only for those classified as FGR according to the previously mentioned criteria (EFW <3rd centile, CPR and UtA) showed not only less intervention (cesarean delivery rate of 25% of 143 vs 40% 138; P < .06) but also improved neonatal outcomes (composite neonatal morbidity of 9% vs 22%; P < .01). 94 In this series, the qualifying criteria for FGR were EFW <3rd centile in 35.9% (101/ 281), an abnormal uterine Doppler velocimetry in 31% (29/93), an abnormal CPR in 19.6% (55/281), and first-trimester low pregnancy-associated plasma protein-A in the remaining 5% (14/281).
It is likely that in future years maternal blood biomarkers are incorporated as a diagnostic criterion of FGR in composite algorithms, as a marker of placental involvement. 95 Indeed, it has been shown in late-onset FGR that the angiogenic factors correlate with placental findings secondary to underperfusion. 96, 97 Can FGR be present in normally grown babies? It is biologically implausible that all cases of placental insufficiency occur in babies with BW <10th percentile. In fact, perinatal mortality remains higher in babies between the 10th-50th percentile of BW, 98 suggesting that a proportion of cases of placental insufficiency exhibit growth within normal ranges. There is evidence showing that normally growing babies with abnormal CPR have a higher frequency of placental insufficiency as determined by abnormal UtA Doppler. 99 There is evidence coming from large retrospective series on pregnancies attended in a tertiary center that abnormal CPR is associated with perinatal morbidity 77, 100 and mortality, 101 independently of BW. Furthermore, some smaller prospective series on lowrisk populations also suggest this notion. 102 However, the clinical application of these findings remains to be determined. The largest prospective series on unselected pregnancies failed to find predictive value of CPR adverse outcome when performed at 30-34 103 or 35-37 104 weeks. Therefore, even if CPR is a marker of placental insufficiency independent of size, the effectiveness of a strategy based on CPR assessment in the overall population is still to be proven. 105 Antepartum surveillance Contrary to early-onset FGR, late-onset FGR is not associated with a progression of hemodynamic changes, and fetuses only exceptionally display Doppler changes in the UA or ductus venosus. However, progression to severe fetal deterioration and even fetal death can occur rapidly. Evidence from animal models 106 shows that prolongation of pregnancy renders to significant growth restriction (14% fetal weight reduction) and hypoxia (evaluated by magnetic resonance imaging and immunohistochemistry) because of differential loss of placental mass rather than any compromise in fetoplacental blood flow. This finding validates the inability of UA Doppler to safely monitor such fetuses.
This might be explained by reduced tolerance to hypoxia of the term in comparison with the preterm fetus and the more common presence of uterine contractions. Therefore, the strategy in the management of late-onset FGR is essentially based on risk assessment. Concerning surveillance, a relevant notion is that the status low-risk vs highrisk, and consequently the recommended management, can change after ajog.org Expert Reviews an initial diagnosis, and for these reason serial measurements of the biometrics and Doppler are recommended.
There is evidence from 1 randomized trial 107 that when compared with monitoring every 2 weeks, twice-a-week monitoring results in more inductions (82% of 70 vs 66% of 54; P ¼ .02), without any improvement in the perinatal outcomes. Thus, the standard of care for those low-risk SGA would be this latter regimen. However, in lateonset FGR such definition of "low-risk SGA" could not be reliably trusted on the umbilical Doppler, because it does not reflect any progression from diagnosis to delivery. 5 Therefore, some other monitoring markers are needed.
Serial growth assessment
Ultrasound growth assessment should not be performed more frequently than every 2 weeks because the inherent error associated with ultrasonographic measurements can preclude an accurate assessment of growth. 108 The advantage of longitudinal over cross-sectional assessment has not been clearly demonstrated.
Amniotic fluid volume
In a large randomized controlled trial on late SGA, 109 one third had oligohydramnios, as defined by an amniotic fluid index <5. However, compared with the single deepest vertical pocket, the amniotic fluid index results in an overdiagnosis of oligohydramnios. 110 In a prospective series of pregnancies with oligohydramnios and FGR, 111 the fetal growth centile remained stable over the 8 weeks following the diagnosis, suggesting that the oligohydramnios is not reflecting any risk of progression. Furthermore, a meta-analysis 112 of 18 trials showed an association with abnormal 5-minute Apgar, but not with acidosis or perinatal death in SGA (RR, 1.6; 95% CI, 0.9e2.6). Because of the limited evidence, the inclusion of oligohydramnios assessment in management protocols of SGA/FGR is not recommended.
Brain Doppler
Hypoxemia secondary to placental insufficiency sets into motion phenomena of circulatory redistribution mainly characterized by the centralization of blood flow. The better oxygenated blood goes toward the most vital organs (brain, heart, adrenals), while vasoconstriction limits the blood's arrival at the organs considered less indispensable. This constellation of changes is known as hemodynamic redistribution. Among them, Doppler MCA assessment has been the most widely studied parameter. Figure 2 shows the progression of changes in the MCA.
Longitudinal studies in late-onset SGA cases have shown that MCA becomes abnormal in about 15% of the cases. 5 It has been shown 83, 113 that in near-term SGA fetuses, MCA could be useful to predict adverse outcome, independently of the UA Doppler. Remarkably, a study where clinicians were blinded to the Doppler indices compared SGA babies with normal and abnormal MCA, reporting 6 times as many instances of emergent cesarean delivery for fetal distress (29% vs 4.8%; P < .001) and a 3-fold increased risk of neonatal metabolic acidosis (7.6% vs 2.4%; P ¼ .03) at labor induction. 114 This is a relevant issue because according current guidelines, 38, 39 labor induction at term is the current standard of care of late-onset SGA. Therefore, while an association exists between abnormal MCA and adverse outcome that would justify its use as surveillance tool, this sign is rather a late manifestation, with acceptable specificity but low sensitivity for clinical applicability. 90 Due to increased impedance in the placental vasculature in combination with a decrease in cerebral resistance secondary to vasodilation, the ratio between the MCA and UA (ie, the CPR) is decreased even with UA and MCA values very close to normal. 89 Consistently, animal models demonstrated that this ratio is better correlated with hypoxia than its individual components. 87 In late SGA fetuses, CPR becomes abnormal in w20% of cases. 5, 94 The CPR improves the sensitivity of UA and MCA alone, because it is already decreased when its individual components are still within normal ranges. 87, 88 A recent systematic review 90 found that in fetuses with SGA born >32 weeks of gestational age, CPR (9 studies) adds value to assessment over MCA (8 studies) in predicting adverse outcomes. Therefore, the CPR could be seen as the primary surveillance tool in late SGA. Several references have been published on CPR and different cut-offs have been used in the literature. 115 A CPR calculator that included most used references is available at: http://www. ajog.org/pb/assets/raw/Health%20Advance/ journals/ymob/CPR/index.htm.
Uterine Doppler
Uterine Doppler is a noninvasive surrogate of the placental function of the maternal compartment. In late SGA it has been found to be associated with a higher frequency of placental sign of maternal underperfusion.
116 Figure 3 shows the spectrum of abnormalities in the UtA waveform.
Interestingly, about a third of pregnancies with abnormal third trimester uterine Doppler had normal values at the beginning of the pregnancy, and this group still has an exceedingly high incidence (w30%) of placenta-related diseases. 117 This suggests that the uterine Doppler has the potential advantage of capturing placental insufficiency from differing pathways: that resulting from defective trophoblastic invasion early in pregnancy, but also that emerging late in pregnancy and probably related to other pathological mechanisms.
At diagnosis, late SGA with abnormal uterine Doppler has a 2-fold increased risk (62.7% vs 34.6%; P < .01) of developing abnormal brain Doppler indices before induction of labor.
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This may be of value in planning the timing of fetal surveillance. In addition, serial uterine Doppler assessment as a surveillance tool has doubtful value because longitudinal studies fail to show any progression from diagnosis to delivery. 5 Timing and mode of delivery Several guidelines recommend delivery at 37-38 weeks. 38, 39 This recommendation is based on the findings of the DIGITAT study, 109 in which 650 women with SGA >36 weeks were randomized to Expert Reviews ajog.org induction or expectant management. Induction group infants were delivered 10 days earlier (266 vs 277 days; mean difference e9.9 days; 95% CI, e11.3 to e8.6) and weighed 130 g less (mean difference e130 g; 95% CI, e188 to e71 g) than babies in the expectant monitoring group. There was no difference in the perinatal outcomes except that women in the expectant group had a 2-fold increase in risk of developing preeclampsia (3.7% of 321 vs 7.9% of 329; mean difference e4.2; 95% CI, e7.7 to e0.6). A total of 17/321 (5.3%) infants in the induction group experienced the composite adverse neonatal outcome, compared with 20/ 329 (6.1%) in the expectant monitoring group (difference e0.8%, 95% CI, e4.3 to 3.2%). This was defined as 5-minute Apgar <7, UA pH <7.05, or admission to neonatal intensive care. The prevalence of these outcomes was 9/650 (1.4%), 14/567 (2.5%), and 22/650 (3.4%), respectively.
In a secondary analysis, 119 a higher percentage of neonatal admissions was found after induction <38 weeks' gestational age: 125 (61%) admissions vs 92 (44%) after expectant management, difference 16% (95% CI, 6.7e26%; P ¼ .001). This suggests that if induction is considered, it is reasonable to delay until 38 weeks. Cesarean deliveries were performed on 45 (14.0%) mothers in the induction group and 45 (13.7%) in the expectant monitoring group (difference 0.3%, 95% CI, e5.0 to 5.6%).
After a response rate of w50%, 2-year evaluation was performed of neurodevelopment (ASQ) and neurobehavior (Child Behavior Checklist [CBCL]). A total of 27% of 274 infants had an abnormal score on the ASQ and 13% of 265 on the CBCL. Results of the ASQ and the CBCL did no differ between expectant and induction arms. 67 The most predictive factors for abnormal ASQ was a BW <2.3 centile (OR, 3.6; 95% CI, 1.5e8.8).
A health economics analysis 120 demonstrated that both strategies (induction vs expectant management) generated comparable costs: on average V7106 per patient for the induction group (N ¼ 321) and V6995 for the expectant management group (N ¼ 329) with a cost difference of V111 (95% CI, V1296e1641).
In the DIGITAT study all SGA fetuses were managed under a common protocol without any attempt to differentiate between low-risk SGA and high-risk FGR. As discussed above, a combination of biometric and Doppler parameters allows profiling a subgroup of fetuses that concentrates most instances of adverse outcomes. 10 While delivery of high-risk FGR at 38 weeks is justified, a more expectant management could be offered to low-risk SGA. An observational study 94 compared a strategy of systematic induction of late SGA at 37 weeks (n ¼ 138) with risk stratification and induction indicated by severe smallness, abnormal CPR, or abnormal uterine Doppler velocimetry (n ¼ 143). The incidence of neonatal composite adverse outcomes was lower after selective induction (9% vs 22%; P < .01). This was defined as the presence of at least 1 of the following conditions: Apgar <7 at 5 minutes, cord arterial pH <7.10, hypoglycemia (blood glucose <2.5 mmol/L), and ventilation. The individual prevalence of these outcomes was 3/281 (1.1%), 5/98 (5%), 25/240 (10.4%), and 28/281 (10%), respectively. Furthermore, neonatal admission was also more frequent after systematic induction (13% v 42%; P < .01). Furthermore, cesarean delivery rates (25% vs 40%; P ¼ .06) were lower after selective induction. This study suggests that protocol-based management of SGA babies may improve outcomes and that identification of moderate SGA should not alone prompt delivery.
Conclusions
First-or second-trimester screening strategies provide limited DR for late SGA. At third trimester, universal screening triples the DR of late SGA compared to clinically indicated scanning. As opposed to early third-trimester ultrasound, scanning late in pregnancy (around 37 weeks) increases the DR for BW <3rd and 10th centile.
UA Doppler velocimetry alone does not provide good differentiation between low-risk SGA and high-risk FGR. A combination of biometric parameters (with severe smallness usually defined as EFW or AC <3rd centile) with Doppler criteria of placental insufficiency (either in the maternal [uterine Doppler] or fetal [CPR] compartments) offers a classification tool that correlates with the risk for adverse perinatal outcome. For surveillance purposes, CPR is sensitive to reflect progression from diagnosis until term. There is no evidence that induction of late FGR at term improves the perinatal outcomes nor is it a cost-effective strategy, and it may increase neonatal admission when performed <38 weeks.
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